CD44 and cancer: designed and developed a poly (lactic-co-glycolic acid) (PLGA) nanoparticle for the CD44-targeted delivery of anticancer drug molecules, salinomycin (SLM) to kill cancer stem cells (CSCs) and paclitaxel to weaken cancerous cells.